show episodes
 
New and emerging strategies for diagnosing rheumatoid arthritis (RA) are continually being explored in research, and many show promising and effective application for real-world clinical practice. To facilitate diagnosis and therefore early treatment of the disease, clinicians should be aware of validated assessment tools, which can be effectively applied in real-world practice settings. Further, monitoring of disease activity and progression using an outcome measure is a valuable and import ...
 
Dr. Clifton Bingham from the Johns Hopkins Arthritis Center begins with a review of current best practices, including the issues related to diagnosis. Dr. George Lawry will follow with an overview of the risks and benefits of biologic therapy for patients with RA before Dr. Bingham presents on emerging DMARDs.The second half of the nearly 2 hour presentation covers the subject of comorbidities, presented by Dr. Lawry, on how to recognize comorbidities and how to best manage them. Dr. Bingham ...
 
Biologic Therapy in Rheumatoid Arthritis: Pioneers in Research, is a monthly series of podcasts featuring interviews with today's giants in rheumatology sponsored by Schering-Plough Corporation. In this series brought to you by Rheumatology News International, you will hear some of the greatest scientists in rheumatology describe the exploration of what was then uncharted medical territory. Their words will bring alive the journey of discovery that placed them in the annals of history's grea ...
 
The gap between optimal care and usual care is sizable for many common but devastating diseases like rheumatoid arthritis (RA). In particular, poor treatment adherence on national and international levels remains a significant, inadequately addressed cause of poor health quality.
 
Each program will provide the listener with evidenced-based arthritis information on topics ranging from arthritis research to effective and safe exercise for people living with arthritis. JointHealth™ podcasts feature conversations with leading Canadian rheumatologists and an arthritis patient advocate.
 
This is the coached running podcast for the 2009 Jingle Bell Run/Walk. If you would like to learn more about where to sign up for this year's Jingle bell Run/Walk or how you can help raise funds to support the Arthritis Foundation, please visit our website at www.arthritis.org.If you would like to locate other coached running podcasts, including a free 8 week coached 5K training program, please visit www.5K101.com
 
When managing rheumatoid arthritis, monitoring disease progression is a cornerstone of effective treatment. "You can't manage what you don't measure." Strategies and tools for assessing disease activity must therefore be included as part of a comprehensive treatment armamentarium. Clinicians are also challenged with application of guidelines that do not seem to "fit" specific, complex, clinical circumstances. In this CME Outfitters Webcast, expert faculty will review the 2010 ACR/EULAR algor ...
 
Rheumatoid arthritis is a chronic long term condition that principally attacks flexible joints, causing painful swelling, stiffness and fatigue. The risk of developing RA is associated with ageing but it also affects adults of working age and is three times more common in women. 56 year old Liz noticed her first symptoms in 1996, when her son was just 2 years old. In this collection, she shares her experiences of living with RA, from early symptoms to drug-controlled remission.
 
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease affecting over 1.3 million Americans and as much as 1% of the worldwide population. The condition can be difficult to diagnose in its early stages because of non-specific early signs and symptoms that mimic many other diseases, and there is no singular confirmatory blood test or physical finding. But the evidence is clear: early diagnosis and treatment lead to improved outcomes for RA patients.Rheumatoid Arthritis: Addres ...
 
Loading …
show series
 
Guest: Alan Epstein, MD Overproduction of the cytokine interleukin 6 (IL-6) has been implicated in the pathogenesis of rheumatoid arthritis and is a critical driver of the inflammatory and destructive aspects of the disease. Dr. Alan Epstein, Clinical Professor of Medicine at the University of Pennsylvania School of Medicine, talks about IL-6’s ...…
 
Guest: Jeffrey Curtis, MD Dr. Jeffrey Curtis, William J. Koopman Endowed Professor in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, explores how precision medicine could revolutionize patient care for rheumatoid arthritis. Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Cont ...…
 
Guest: Jeffrey Curtis, MD Guest: Alan Epstein, MD Guest: Farhan Tahir, MD Guest: Michele Meltzer, MD What's in store for the treatment of RA days, months, and years from now? Hear from top rheumatologists about what the future holds for patients with rheumatoid arthritis and the health care professionals striving to improve their quality of lif ...…
 
Guest: Farhan Tahir, MD Dr. Farhan Tahir, staff rheumatologist at Cancer Treatment Centers of America in Philadelphia, PA talks about ways in which management approaches for RA patients have evolved over time, such as the drive toward earlier diagnosis and treatment. Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content fo ...…
 
Guest: Jeffrey Curtis, MD Dr. Jeffrey Curtis, William J. Koopman Endowed Professor in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, talks about the problem of settling for insufficient therapeutic responses in RA treatments, how to recognize when it's happening, and what health professionals ca ...…
 
Guest: Robin Dore, MD Dr. Robin Dore, Clinical Professor of Medicine at UCLA's David Geffen School of Medicine in Los Angeles, CA diagrams the JAK-STAT pathway as it relates to inflammatoty change and RA disease progression. Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series i ...…
 
Guest: Michele Meltzer, MD Dr. Michele Meltzer, Associate Professor at Jefferson University Hospitals in Philadelphia, examines the reasons why many patients have advanced rheumatoid arthritis by the time they see a rheumatologist to treat the disease. Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-ce ...…
 
Guest: Alan Epstein, MD Dr. Alan Epstein, Clinical Professor of Medicine at the University of Pennsylvania School of Medicine, shares insights on the molecular mechanisms of inflammatory change in RA, and the effects of inhibiting the JAK-STAT pathway responsible for disease progression. Rheumatoid Arthritis: Addressing Unmet Needs is sponsored ...…
 
Guest: Jeffrey Curtis, MD Dr. Jeffrey Curtis, William J. Koopman Endowed Professor in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, talks about what every new rheumatologist should know when starting out. Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non ...…
 
Guest: Farhan Tahir, MD Dr. Farhan Tahir, staff rheumatologist at Cancer Treatment Centers of America in Philadelphia, PA shares effective techniques that physicians can utilize to talk with rheumatoid arthritis patients about their disease management. He explores the importance of having an open dialogue with patients, and key factors to consi ...…
 
Guest: Jeffrey Curtis, MD Dr. Jeffrey Curtis, William J. Koopman Endowed Professor in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, talks about top methods for describing the RA disease course to patients. Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a no ...…
 
Guest: Robin Dore, MD Dr. Robin Dore, Clinical Professor of Medicine at UCLA's David Geffen School of Medicine explores how pregnant patients and fertile women considering pregnancy can manage their rheumatoid arthritis. Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series is pr ...…
 
Radio Interview with Dr Louis McGuigan Radio 2MAX FM Interview with rheumatologist Dr Louis McGuigan Purpose: To discuss the different forms of arthritis; the challenges faced by regional and rural residents living and managing their condition and the benefits of our Rural Outreach Project which visited Cowra in 2014. Date: 20 October 2014 Leng ...…
 
Dr. Clifton Bingham from the Johns Hopkins Arthritis Center begins with a review of current best practices, including the issues related to diagnosis. Dr. George Lawry will follow with an overview of the risks and benefits of biologic therapy for patients with RA before Dr. Bingham presents on emerging DMARDs.The second half of the nearly 2 hou ...…
 
Liz, who was diagnosed with RA in 1996, talks about living with this long term condition.
 
Liz talks about how she felt, physically and emortionally, when the condition first manifested itself.
 
Liz looks back on about the protracted process of getting a diagnosis.
 
Liz talks about the various medications she has had since her condition was first diagnosed and how she is now in drug-controlled remission.
 
Liz reflects on how her life has changed as a result of her long term condition.
 
In this CME Outfitters Webcast, expert faculty will demonstrate ways that clinicians can improve their understanding and management of patients with fibromyalgia through the use of measurement-based tools in routine clinical practice.
 
In this CME Outfitters Live and On Demand activity, expert faculty will comprehensively analyze and discuss strategies for early diagnosis, early and sustained DMARD therapy, and measurement-based care that will help clinicians improve care of their patients with RA.
 
In this CME Outfitters Webcast, expert faculty will review the 2010 ACR/EULAR algorithm; recommend strategies and tools for assessing disease activity and provide insights for integrating evidence-based guidelines for the management of RA into clinical practice.
 
This is the coached running podcast for the 2009 Jingle Bell Run/Walk. To learn more or register today for the Jingle Bell Run/Walk for Arthritis, visit www.arthritis.org. If you would like to locate other coached running podcasts, including a free 8 week coached 5K training program, please visit www.runningmatemedia.com. The Arthritis Foundati ...…
 
This sixth podcast program, Individualizing Therapy: Today’s Options, Tomorrow’s Opportunities, features an interview with Professor McInnes. He discusses the current state of knowledge in rheumatoid arthritis and directions for discovery in coming years.By rhnews@elsevier.com (Rheumatology News International).
 
This fifth podcast titled Progress and Prognosis: Evaluating Patients’ Responses to Biologic Therapy features a telephone interview with Professor Schett. He discusses differences among the anti-TNF agents in the treatment of rheumatoid arthritis.By rhnews@elsevier.com (Rheumatology News International).
 
Professor VonVollenhoven discusses factors which distinguish individual responses by patients with rheumatoid arthritis to various anti-TNF agents. He describes observations of radiologic and clinical progression of illness in subgroups of patients and provides an overview of considerations in choosing one pharmacologic agent over another. Prof ...…
 
Contemporary research shows that the early diagnosis and treatment of RA can offer patients the possibility of achieving remission. The goal for any patient with early RA should be to achieve remission. If a patient does not already have joint damage, the goal should be a normal acute-phase response and no swollen joints as soon as possible.…
 
Professor Smolen discusses the evidence supporting the ability of TNF-alpha agents to result in substantial and sustained improvement in symptoms of psoriatic arthritis. Agents including infliximab and etanercept result in not only clinical improvement but also slow the radiographic progression of joint disease and damage. Further, the combinat ...…
 
Professor Sir Ravinder Maini's groundbreaking work on the characterization of TNF-alpha began in the mid-1980's with his collaboration with Professor Mark Feldman. In his study of intercellular messenger molecules, Professor Sir Maini utilized two new technologies -- protein sequencing and cDNA protein coding -- to investigate half a dozen cyto ...…
 
Topics of discussion include: Becoming a research scientist; Dr. Lacaille's work at the Arthritis Research Centre of Canada; Dr. Lacaille's work at the Canadian Arthritis Network; Looking to the future of arthritis research in Canada; 2007 YWCA Women of Distinction Award finalist.
 
Topics discussed with Dr. Shojania include: The challenge of getting diagnosed; The impact of the diagnosis; Accepting one's diagnosis; Learning about one's treatment options; The basics about non-steroidal anti-inflammatory medications (NSAIDs) - when do they get used and why, what do they not do; The basics about disease modifying anti-rheuma ...…
 
Gordon Whitehead is a consumer advocate living with rheumatoid arthritis. This 60 minute program is intended to give the consumer/public listener an overview of the following: Learning about the Alliance for the Canadian Arthritis Program. Who is the Alliance? Why create an alliance? What has the Alliance accomplished since it formed?; National ...…
 
Ms. Jay Fiddler is a consumer advocate who lives with Stills disease. This 48 minute program provides the listener with an overview of the different ways that people with arthritis can participate in health research decision-making. Topics covered include the following: How people with arthritis participating in arthritis research decision-maki ...…
 
Dr. Lacaille is Assistant Professor, Division of Rheumatology Department of Medicine, UBC. She is an award-winning researcher and frequent conference speaker. Dr. Lacaille was the recipient of a Canadian Arthritis Network grant to develop a population-based registry of people with rheumatoid arthritis in BC, and has also won scholarships from t ...…
 
Dr. Linda Li is an Assistant Professor at the School of Rehabilitation Sciences, University of British Columbia. In 2006, she was the first rehabilitation professional appointed to the role of Harold Robinson / Arthritis Society Chair in Arthritic Diseases. This 40 minute program provides the consumer/public listener with information on the ben ...…
 
Dr. Shojania is a leader in the field of rheumatology. His research specialty is the efficacy of different medications on the treatment of rheumatoid arthritis. This 35 minute program provides the consumer/public listener with an overview of the various aspects of an evidence-based treatment plan for inflammatory arthritis, including the follow ...…
 
Dr. John Esdaile is Professor and Head, Division of Rheumatology Department of Medicine, University of British Columbia. He is an internationally respected rheumatologist who spearheaded the creation of the Arthritis Research Centre of Canada. This program provides the listener with an overview of arthritis research, including the following top ...…
 
Google login Twitter login Classic login